Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Show other versions (1)

Xehetasun bibliografikoak
Egile Nagusiak:	Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, McShane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	Public Library of Science 2008
Gaiak:	Medical sciences Vaccinology Infectious diseases

Antzeko izenburuak

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
nork: Hanekom, W, et al.
Argitaratua: (2008)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
nork: Willem A Hanekom, et al.
Argitaratua: (2008-07-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
nork: Harris, S, et al.
Argitaratua: (2013)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
nork: Ruggeberg, J, et al.
Argitaratua: (2007)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
nork: Matsumiya, M, et al.
Argitaratua: (2014)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
nork: Poyntz, HC
Argitaratua: (2012)

Editorial: Reverse Vaccinology
nork: Richard Moxon, et al.
Argitaratua: (2019-12-01)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
nork: Warrell, M, et al.
Argitaratua: (2008)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
nork: Pollard, A, et al.
Argitaratua: (2004)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
nork: Wang, LT
Argitaratua: (2022)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
nork: Ronan, E
Argitaratua: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
nork: Griffiths, K
Argitaratua: (2012)

Innate immune responses to tuberculosis vaccines
nork: Matsumiya, M
Argitaratua: (2014)

B cell responses to conjugate and polysaccharide meningococcal vaccines
nork: Ramasamy, M
Argitaratua: (2012)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
nork: Bauza, K
Argitaratua: (2012)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
nork: Alharbi, N
Argitaratua: (2014)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
nork: Hennig, B, et al.
Argitaratua: (2008)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
nork: Antrobus, R
Argitaratua: (2014)

Data Behind Vaccine Hesitancy and Latest Updates on Vaccines in the Pipeline—2019 Annual Conference on Vaccinology Research, April 3–5, 2019
nork: William Schaffner, et al.
Argitaratua: (2020-01-01)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
nork: Ochiai, R
Argitaratua: (2011)

Antibody-based HIV-1 vaccines: recent developments and future directions
nork: Montefiori, D, et al.
Argitaratua: (2007)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
nork: Elias, SC
Argitaratua: (2014)

The Vaccinia Virus A36R Protein Is a Type Ib Membrane Protein Present on Intracellular but Not Extracellular Enveloped Virus Particles
nork: Van Eijl, H, et al.
Argitaratua: (2000)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
nork: Kelly, C
Argitaratua: (2013)

Epitope dominance studies with serotype O foot-and-mouth disease
nork: Borley, DW
Argitaratua: (2012)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
nork: Olotu, A
Argitaratua: (2013)

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
nork: Ahmed, T, et al.
Argitaratua: (2014)

HIV-specific interleukin-10 responses and immune modulation
nork: Clutton, G
Argitaratua: (2012)

Vaccines for the 21st century
nork: Isabel Delany, et al.
Argitaratua: (2014-05-01)

The role of lung tissue-resident memory T cells in protection against tuberculosis
nork: Bull, N
Argitaratua: (2017)

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
nork: Wan, L, et al.
Argitaratua: (2012)

Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system
nork: Sadarangani, M
Argitaratua: (2011)

Architecture of the HIV-1 glycan shield
nork: Pritchard, L
Argitaratua: (2014)

T-cell receptor (TCR) usage in HIV-2 infection
nork: Moysi, E
Argitaratua: (2012)

Enhancing the efficacy of viral vector blood-stage malaria vaccines
nork: Forbes, E
Argitaratua: (2011)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
nork: Lee, Y, et al.
Argitaratua: (2008)

Editorial: Precision vaccinology for infectious diseases
nork: Mahbuba Rahman, et al.
Argitaratua: (2024-04-01)

Vaccine Evolution and Its Application to Fight Modern Threats
nork: Emanuele Andreano, et al.
Argitaratua: (2019-07-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
nork: Pinpathomrat, N
Argitaratua: (2018)

Global epidemiology of meningococcal disease and vaccine efficacy
nork: Pollard, A
Argitaratua: (2004)